Done early enough, personalized, patient data-driven multi-cancer screening will save lives. But are we there yet?
Some nine sets of metagenomic and transcriptomic biomarkers outperformed existing clinical prediction models
Newly developed computational tool accurately identifies, characterizes, and differentiates cell types in tumor samples
Through this "polygenic risk scoring," researchers can identify people at high risk for disease, even if they don't present other warning signs